Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients.

Authors

Ammar Sukari
Misako Nagasaka
Maria Diab
Khaled Al Sibai
Bassel Atassi
Jailan A Elayoubi, Beaumont Health Resident
Seongho Kim
Ömer Küçük

Document Type

Article

Publication Date

7-1-2019

Publication Title

Clinical Otolaryngology

Volume

44

Issue

4

First Page

639

Last Page

643

Recommended Citation

Sukari A, Nagasaka M, Diab M, Al Sibai K, Atassi B, Elayoubi JA, Kim S, Küçük Ö. Cetuximab and methotrexate in recurrent or metastatic head and neck squamous cell carcinoma-A single institution analysis of 54 patients. Clin Otolaryngol. 2019 Jul;44(4):639-643. doi: 10.1111/coa.13316. Epub 2019 Apr 1. PMID: 30784192; PMCID: PMC6844146.

DOI

10.1111/coa.13316

ISSN

1749-4486

PubMed ID

30784192